Effects of chronic ethanol administration and ethanol withdrawal on cyclic guanosine 3',5'-monophosphate (cGMP) levels in the rat brain
- PMID: 15072807
- DOI: 10.1016/j.drugalcdep.2003.11.011
Effects of chronic ethanol administration and ethanol withdrawal on cyclic guanosine 3',5'-monophosphate (cGMP) levels in the rat brain
Abstract
The main objective of the present study is to investigate the possible effects of chronic ethanol consumption and ethanol withdrawal on cyclic guanosine 3', 5'-monophosphate (cGMP) levels in cerebral cortex, striatum, hippocampus and hypothalamus of rat brain. Ethanol was given to female Wistar rats (225-270g) by a liquid diet for 21 days. cGMP levels were measured in respective brain regions using an EIA kit at 7th, 14th and 21st days of ethanol ingestion and at 6th and 24th h of ethanol withdrawal. cGMP levels in cortex, striatum and hippocampus but not hypothalamus were found significantly increased at 14th and 21st days of ethanol consumption. The most prominent increase was observed in striatal tissues (approximately 350%). cGMP levels of striatum and hippocampus were still remaining significantly high at 6th h of ethanol withdrawal. Blood ethanol levels were found as 115.60, 50.0 and 7.0mg/dl just before and after 6 and 24h of ethanol withdrawal, respectively and audiogenic seizures also occurred at 6th h of ethanol withdrawal with an incidence of 75% in individual parallel groups. Our results suggest that changes of cGMP levels in cerebral cortex, striatum and hippocampus might participate in the mechanism of ethanol dependence and withdrawal in rats.
Similar articles
-
Effects of acute and chronic ethanol administration and withdrawal on adenosine 3':5'-monophosphate and guanosine 3':5'-monophosphate levels in the rat brain.J Pharmacol Exp Ther. 1977 Feb;200(2):298-305. J Pharmacol Exp Ther. 1977. PMID: 190377
-
Alterations in brain cyclic guanosine 3':5'-monophosphate levels after acute and chronic treatment with ethanol.J Pharmacol Exp Ther. 1977 Apr;201(1):103-9. J Pharmacol Exp Ther. 1977. PMID: 15100
-
[Effect of cedemex on cAMP and cGMP levels of different brain areas in morphine withdrawal rats].Zhongguo Zhong Yao Za Zhi. 2008 Jun;33(12):1439-43. Zhongguo Zhong Yao Za Zhi. 2008. PMID: 18837351 Chinese.
-
Serotonergic anti-depressants and ethanol withdrawal syndrome: a review.Alcohol Alcohol. 2008 Jan-Feb;43(1):15-24. doi: 10.1093/alcalc/agm145. Epub 2007 Oct 12. Alcohol Alcohol. 2008. PMID: 17934195 Review.
-
Ethanol-sensitive brain regions in rat and mouse: a cartographic review, using immediate early gene expression.Alcohol Clin Exp Res. 2009 Jun;33(6):945-69. doi: 10.1111/j.1530-0277.2009.00916.x. Epub 2009 Mar 19. Alcohol Clin Exp Res. 2009. PMID: 19302091 Review.
Cited by
-
Cyclic nucleotide phosphodiesterases: potential therapeutic targets for alcohol use disorder.Psychopharmacology (Berl). 2018 Jun;235(6):1793-1805. doi: 10.1007/s00213-018-4895-7. Epub 2018 Apr 16. Psychopharmacology (Berl). 2018. PMID: 29663017 Free PMC article. Review.
-
Phosphodiesterase regulation of alcohol drinking in rodents.Alcohol. 2015 Dec;49(8):795-802. doi: 10.1016/j.alcohol.2015.03.007. Epub 2015 May 29. Alcohol. 2015. PMID: 26095589 Free PMC article. Review.
-
Immune treatments for alcohol use disorder: A translational framework.Brain Behav Immun. 2021 Oct;97:349-364. doi: 10.1016/j.bbi.2021.07.023. Epub 2021 Jul 31. Brain Behav Immun. 2021. PMID: 34343618 Free PMC article. Review.
-
Inhibition of Phosphodiesterase 2 Ameliorates Post-Traumatic Stress-Induced Alcohol Intake Disorder by Regulating cAMP/cGMP Signaling.Int J Neuropsychopharmacol. 2022 Nov 17;25(11):936-945. doi: 10.1093/ijnp/pyac064. Int J Neuropsychopharmacol. 2022. PMID: 36124735 Free PMC article.
-
The foraging gene affects alcohol sensitivity, metabolism and memory in Drosophila.J Neurogenet. 2021 Sep;35(3):236-248. doi: 10.1080/01677063.2021.1931178. Epub 2021 Jun 7. J Neurogenet. 2021. PMID: 34092172 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources